3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
3
Radiodermatitis
2
Neoplasms
2
Multiple Myeloma
2
Adenomatous Polyposis Coli
2
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Mucositis
1
Monoclonal Gammopathy of Undetermined Significance
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Gastritis, Atrophic
1
Fatigue
1
Communicable Diseases
1
Breast Carcinoma In Situ
1
Adenocarcinoma
1
Interventions
nabiximols
7
Morphine
7
Fentanyl
7
Hydromorphone
6
Tapentadol
5
Radiotherapy
4
Prednisone
3
Methadone
3
Ketamine
3
Duloxetine Hydrochloride
3
Calcium Dobesilate
3
Calcium
3
Analgesia
3
Acetaminophen
3
cabozantinib
2
Zoledronic Acid
2
Surveys and Questionnaires
2
Sugars
2
Radiosurgery
2
Pregabalin
2
Pain Management
2
Oxycodone
2
Minocycline
2
Letrozole
2
Ibuprofen
2
Diclofenac
2
Dexamethasone
2
Cryosurgery
2
Calcium Gluconate
2
Bupivacaine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Pain
×
Curcumin
×
Clear all
NCT02556632
2017-11-06
Curcumin-II
University of Rochester
Phase 2
Completed
191 enrolled
23 charts